Miriam Guerrero-Retuerto

Leon, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Metabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort.

Metabolic effects of GLP-1 receptor agonists in rheumatology patients and inflammatory outcomes: a single-centre retrospective cohort.

Journal: RMD open

Published: April 30, 2026

Interference of Immunosuppressive Therapies with Cellular Antimicrobial Activity Against Mycobacterium abscessus.

Interference of Immunosuppressive Therapies with Cellular Antimicrobial Activity Against Mycobacterium abscessus.

Journal: International journal of molecular sciences

Published: March 11, 2026

DNA from Slow-Growing Mycobacteria in Culture Negative Sputa Reveal Common Exposure to Mycobacteria.

DNA from Slow-Growing Mycobacteria in Culture Negative Sputa Reveal Common Exposure to Mycobacteria.

Journal: Biology

Published: February 20, 2026

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Journal: RMD open

Published: December 22, 2025

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Journal: RMD open

Published: December 22, 2025

Diagnosis of Microscopic Polyangiitis by EBUS-Guided Transbronchial Mediastinal Cryobiopsy: A Case Report.

Diagnosis of Microscopic Polyangiitis by EBUS-Guided Transbronchial Mediastinal Cryobiopsy: A Case Report.

Journal: Diagnostics (Basel, Switzerland)

Published: November 23, 2025

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Journal: The Journal of rheumatology

Published: November 05, 2025

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Journal: The Journal of rheumatology

Published: October 01, 2025

Macitentan in the Treatment of Digital Ulcers in Patients with Systemic Rheumatic Autoimmune Diseases: A National Multicenter Study of 42 Patients.

Macitentan in the Treatment of Digital Ulcers in Patients with Systemic Rheumatic Autoimmune Diseases: A National Multicenter Study of 42 Patients.

Journal: Journal of clinical medicine

Published: September 14, 2025

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study.

Journal: Rheumatology (Oxford, England)

Published: August 27, 2025

Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.

Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.

Journal: Rheumatology (Oxford, England)

Published: August 27, 2025

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case-control study.

DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case-control study.

Journal: Scientific reports

Published: October 18, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026